| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/09/2011 | US20110136185 Epothilones c, d, e, and f, preparation and compositions |
| 06/09/2011 | US20110136100 Non-human animal disease model for hepatitis b virus-associated disease |
| 06/09/2011 | US20110135770 Apples with high polyphenolic content |
| 06/09/2011 | US20110135764 Pest control using natural pest control agent blends |
| 06/09/2011 | US20110135756 Compositions and methods for protecting sensory hair cells |
| 06/09/2011 | US20110135755 Combination therapies for treating neoplastic disease |
| 06/09/2011 | US20110135753 Nutritional Supplement For Patients With Chronic Heart Failure |
| 06/09/2011 | US20110135751 Parenteral administration of pyrophosphate for prevention or treatment of phosphate or pyrophosphate depletion |
| 06/09/2011 | US20110135749 Low shrinkage multifunctional ssq resins |
| 06/09/2011 | US20110135744 Nanoparticle Based Therapy for Dispersing Mucin |
| 06/09/2011 | US20110135743 Carboxyvinyl polymer-containing nanoparticle suspensions |
| 06/09/2011 | US20110135742 Controlled release encapsulated anti-bacterial and anti-inflammatory nanoparticles |
| 06/09/2011 | US20110135739 Oral Formulations of a Hedgehog Pathway Inhibitor |
| 06/09/2011 | US20110135738 Single dosage pharmaceutical formulation comprising eprosartan mesylate |
| 06/09/2011 | US20110135733 Aldehyde conjugated flavonoid preparations |
| 06/09/2011 | US20110135732 Multiple phase cross-linked compositions and uses thereof |
| 06/09/2011 | US20110135731 Abuse-resistant opioid dosage form |
| 06/09/2011 | US20110135724 Ondansetron Orally Disintegrating Tablet Compositions for Prevention of Nausea and Vomiting |
| 06/09/2011 | US20110135723 Pharmaceutical compositions containing pregabalin |
| 06/09/2011 | US20110135722 Pharmaceutical formulation comprising a proton pump inhibitor and antacids |
| 06/09/2011 | US20110135719 Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof |
| 06/09/2011 | US20110135717 Composition for Prevention or Treatment of Hyperlipidemia, Fatty Liver or Obesity |
| 06/09/2011 | US20110135716 Delivery of h2 antagonists |
| 06/09/2011 | US20110135714 Compositions for external application, containing adenosyl cobalamin for improvement of skin diseases |
| 06/09/2011 | US20110135713 Antimicrobial and Antiviral Compounds and Methods for Their Use |
| 06/09/2011 | US20110135712 Biologically Active Taxane Analogs And Methods Of Treatment By Oral Administration |
| 06/09/2011 | US20110135711 Methods and Compositions for Delivery of Catecholic Butanes for Treatment of Tumors |
| 06/09/2011 | US20110135709 Adhesive skin patch |
| 06/09/2011 | US20110135708 Dietary supplement - liquid filled gum |
| 06/09/2011 | US20110135707 Polyhydroxyalkanoates for in vivo applications |
| 06/09/2011 | US20110135703 Antimicrobial Coating for Surgical Implants and Method of Use |
| 06/09/2011 | US20110135700 In situ bulking composition |
| 06/09/2011 | US20110135695 Oral dosage form for controlled drug release |
| 06/09/2011 | US20110135691 Immunomodulation by iap inhibitors |
| 06/09/2011 | US20110135688 Methods and Compositions for Increasing Titer of Recombinant Porcine Adenovirus-3 Vectors |
| 06/09/2011 | US20110135687 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 06/09/2011 | US20110135684 Use of L-alpha-lysophosphatidylcholine to obtain the differentiation of monocytes in mature dendritic cells in vitro |
| 06/09/2011 | US20110135674 Markers of XMRV Infection and Uses Thereof |
| 06/09/2011 | US20110135671 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 06/09/2011 | US20110135670 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 06/09/2011 | US20110135669 Synthetic agonists of tlr9 |
| 06/09/2011 | US20110135668 Compounds and compositions as protein kinase inhibitors |
| 06/09/2011 | US20110135663 Anti-igf-ir antibodies and uses thereof |
| 06/09/2011 | US20110135658 Vhz for diagnosis and treatment of cancers |
| 06/09/2011 | US20110135656 Method of treating cancer |
| 06/09/2011 | US20110135655 Role of PI3K p110 delta Signaling in Retroviral Infection and Replication |
| 06/09/2011 | US20110135654 Prostate cancer related gene styk1 |
| 06/09/2011 | US20110135652 Novel Use of Idbf |
| 06/09/2011 | US20110135651 Method and composition for enhancing hematopoietic stem cell mobilization |
| 06/09/2011 | US20110135650 Morpholinone compounds as factor ixa inhibitors |
| 06/09/2011 | US20110135647 Genes and polypeptides relating to breast cancers |
| 06/09/2011 | US20110135646 Genes of an Otitis Media Isolate of Nontypeable Haemophilus influenzae |
| 06/09/2011 | US20110135642 Pharmaceutical Compositions Comprising Antibodies Binding To EBV (Ebstein-Barr Virus) Protein BARF1 |
| 06/09/2011 | US20110135641 Radioprotectants targeting thrombospondin-1 and cd47 |
| 06/09/2011 | US20110135640 Identification of tumour-associated cell surface antigens for diagnosis and therapy |
| 06/09/2011 | US20110135638 Actriib proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy |
| 06/09/2011 | US20110135632 Methods for the modulation of angiogenesis |
| 06/09/2011 | US20110135629 EYA2S As Modifiers of the PTEN/AKT Pathway and Methods of Use |
| 06/09/2011 | US20110135627 Pain relief composition, system and method |
| 06/09/2011 | US20110135622 Presbyopia Treatment by Lens Alteration |
| 06/09/2011 | US20110135619 Polypeptides of Alicyclobacillus sp. |
| 06/09/2011 | US20110135618 Methods of treating cancer with doxazolidine and prodrugs thereof |
| 06/09/2011 | US20110135613 Methods for treating apolipoprotein e4-associated disorders |
| 06/09/2011 | US20110135612 Compositions to effect neuronal growth |
| 06/09/2011 | US20110135607 Viral nucleic acid for the treatment of neurodegenerative disorders |
| 06/09/2011 | US20110135605 Methods and products related to treatment and prevention of hepatitis c virus infection |
| 06/09/2011 | US20110135604 Antiviral compounds |
| 06/09/2011 | US20110135603 Inhibitors of phosphatidylinositol 3-kinase |
| 06/09/2011 | US20110135601 Bicycloaniline derivative |
| 06/09/2011 | US20110135600 Bicyclic traizole derivatives for treating of tumors |
| 06/09/2011 | US20110135599 Antiviral compounds |
| 06/09/2011 | US20110135598 Methods to diagnose and immunize against the virus causing human merkel cell carcinoma |
| 06/09/2011 | US20110135597 Uses of Mammalian Cytokine; Related Reagents |
| 06/09/2011 | US20110135595 Neuregulin based methods and compositions for treating cardiovascular disease |
| 06/09/2011 | US20110135594 Oxindolyl inhibitor compounds |
| 06/09/2011 | US20110135593 Sterilizing polymer and method of preparation thereof |
| 06/09/2011 | US20110135584 Pharmaceutical/cosmetic, e.g., anti-acne compositions comprising at least one naphthoic acid compound, benzoyl peroxide and at least one film-forming agent |
| 06/09/2011 | US20110135582 Combination of medicaments for the treatment of respiratory diseases |
| 06/09/2011 | US20110135580 Novel Medicament Combinations for the Treatment of Respiratory Diseases |
| 06/09/2011 | US20110135579 RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF GLAUCOMA |
| 06/09/2011 | US20110135577 Superparamagnetic nanoparticles IN MEDICAL THERAPEUTICS and manufacturing method THEREOF |
| 06/09/2011 | US20110135574 Methods of treating kidney disease |
| 06/09/2011 | US20110135571 Hybrid nanoparticles as anti-cancer therapeutic agents and dual therapeutic/imaging contrast agents |
| 06/09/2011 | US20110132376 Topical antiviral formulations |
| 06/09/2011 | US20110132357 Compositions, methods & systems for respiratory delivery of two or more active agents |
| 06/09/2011 | DE102009056886A1 cMet-Inhibitoren zur Behandlung der Endometriose cMet inhibitors for the treatment of endometriosis |
| 06/09/2011 | DE102009056636A1 Raltegravir-Polymorphe Raltegravir polymorphs |
| 06/09/2011 | DE102009056597A1 Use of flavin derivatives and their salts for preparing a medicament for the treatment of pathologies of the internal limiting membrane (ILM), and the flavin derivative is riboflavin or roseoflavin |
| 06/09/2011 | CA2818233A1 Salacinol and ponkoranol homologues, derivatives thereof, and methods of synthesizing same |
| 06/09/2011 | CA2782911A1 Liposome of irinotecan or its hydrochloride and preparation method thereof |
| 06/09/2011 | CA2782727A1 2-pyridone compounds |
| 06/09/2011 | CA2782704A1 Diphenyl-pyrazolopyrdine derivatives, preparation thereof, and use thereof as nuclear receptor not modulators |
| 06/09/2011 | CA2782684A1 Pyrazolopyrimidines and related heterocycles as ck2 inhibitors |
| 06/09/2011 | CA2782631A1 Treatment of infectious diseases |
| 06/09/2011 | CA2782625A1 Treatment of allodynia and hyperalgesia |
| 06/09/2011 | CA2782556A1 Amantadine compositions and methods of use |
| 06/09/2011 | CA2782529A1 Morphinan derivatives for the treatment of drug overdose |
| 06/09/2011 | CA2782441A1 Topical use of hydroxytyrosol and derivatives for the prevention of hiv infection |
| 06/09/2011 | CA2782380A1 Liquid compositions comprising vitamin d and uses thereof |
| 06/09/2011 | CA2782314A1 Method of treatment of cns disorders |